CUE · TickerCove

CUECue Biopharma, Inc.as of 2026-09-16

Horizon

Issued 2026-09-16 at $34.17 · now $34.17 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, CUE has typically landed between $21.99 and $49.66 — a range of −35.7% to +45.3% from the issuance price $34.17.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.

Actual close
Typical path (median)
Middle 50% of outcomes
90% range

2,155 overlapping 1 month windows · 2018-01-02 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($34.17) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

52-week range$34.17 · 92% of range

$5.31 low$36.78 high

Trailing 52 weeks to 2026-09-16 — factual context, not a signal.

Base rate up · monthiClimatology base rate that a US-listed stock rises over a month, with its 90% CI and ≈1,408 effective observations. Not a call on this stock — we have no evidence its odds differ.

53.9%

90% CI 51.7%–56.1%

Distribution · month iiThe price-anchored range: typical move (median), and the p90 downside/upside — 90% of similar periods stayed inside these. Ranges, not a prediction of direction.

−7.8%

typical move · IQR 32.7%

−35.7%worst (p90)+45.3%best (p90)

Insider convictioniOpen-market common-stock purchases by company insiders in the last 90 days (grants and option exercises excluded). Historical tendency, not advice — detail below.

conviction buys

0 open-market sales

Congress disclosuresiRecent disclosed congressional trades for this company. Purchase clusters (≥2 members buying within 90 days) historically preceded a modestly higher forward return (+32 bp/mo in 2022–2026, +45 bp/mo in 2015–2021) — a descriptive tendency, not a forecast input. Detail below.

0 buys · 0 sells · 0 members

cluster tilt persisted, ~halved after 2021

Where CUE has typically landed a month from the 2026-09-16 close of $34.17 — the range is history, not a prediction.

now $34.17 (+0.0%)
typical $31.49 (-7.8%)
middle 50% $25.89–$37.08
90% range $21.99–$49.66

Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 2,155 windows spanning 2018-01-02 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.

Start	Return	Max drop	Max rise
3 worst
2025-11-24	−59.2%	−59.2%	+6.7%
2025-11-21	−59.1%	−59.1%	+5.9%
2025-11-26	−55.7%	−61.5%	+0.7%
3 best
2026-04-06	+558.0%	+0.0%	+558.0%
2026-04-07	+501.4%	+0.0%	+518.4%
2026-04-02	+452.8%	−1.7%	+463.3%

2,155 overlapping windows · 2018-01-02 – 2026-09-16 · not cherry-picked

Seasonality · by month i

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~9 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.

Jan

63%

+5.1%

n=8

Feb

33%

−5.7%

n=9

Mar

22%

−6.3%

n=9

Apr

56%

+18.6%

n=9

May

44%

+5.4%

n=9

Jun

33%

−5.1%

n=9

Jul

44%

−7.2%

n=9

Aug

44%

−4.6%

n=9

Sep

44%

−0.6%

n=9

Oct

50%

+7.5%

n=8

Nov

63%

+7.5%

n=8

Dec

38%

−8.3%

n=8

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Date	Person	Role	Action	Shares @ price	Value	Ownership Δ	vs S&P 1m	vs S&P 6m	Owned after	Filing
2026-08-13	Lin Shao-Lee	director	Sale	10,460 @ $29.48	$308K	−1.5% of holding	+0.5%	not yet — horizon still open	705,995	Form 4 · filed 1 day after the trade
2026-08-13	Ray Sumita	director	Sale	6,442 @ $30.35	$196K	−5.2% of holding	+0.5%	not yet — horizon still open	118,549	Form 4 · filed 4 days after the trade
2026-08-13	Lin Shao-Lee	director	Sale	5,423 @ $27.19	$147K	−0.7% of holding	+0.5%	not yet — horizon still open	718,830	Form 4 · filed 1 day after the trade
2026-08-13	Meluzio Michael Vincent	officer	Sale	4,106 @ $30.35	$125K	−7.7% of holding	+0.5%	not yet — horizon still open	48,964	Form 4 · filed 4 days after the trade
2026-08-13	Ray Sumita	director	Sale	2,383 @ $29.37	$70K	−1.9% of holding	+0.5%	not yet — horizon still open	124,991	Form 4 · filed 4 days after the trade
2026-08-13	Lin Shao-Lee	director	Sale	2,375 @ $28.11	$67K	−0.3% of holding	+0.5%	not yet — horizon still open	716,455	Form 4 · filed 1 day after the trade
2026-08-13	Meluzio Michael Vincent	officer	Sale	1,519 @ $29.37	$45K	−2.8% of holding	+0.5%	not yet — horizon still open	53,070	Form 4 · filed 4 days after the trade
2026-08-13	Ray Sumita	director	Sale	4 @ $31.13	$125	−0.0% of holding	+0.5%	not yet — horizon still open	118,545	Form 4 · filed 4 days after the trade
2026-08-13	Meluzio Michael Vincent	officer	Sale	3 @ $31.13	$93	−0.0% of holding	+0.5%	not yet — horizon still open	48,961	Form 4 · filed 4 days after the trade
2026-08-12	Lin Shao-Lee	director	Sale	34,225 @ $26.99	$924K	−4.5% of holding	−4.5%	not yet — horizon still open	730,028	Form 4 · filed 2 days after the trade
2026-08-12	Lin Shao-Lee	director	Sale	5,775 @ $27.75	$160K	−0.8% of holding	−4.5%	not yet — horizon still open	724,253	Form 4 · filed 2 days after the trade
2026-06-01	Lin Shao-Lee	director	Purchase	90,906 @ $11.00	$1000K	ownership Δ n/a	+19.2%	not yet — horizon still open	90,906	Form 4 · filed 2 days after the trade
2026-06-01	Lin Shao-Lee	director	Purchase	45,453	—	ownership Δ n/a	+19.2%	not yet — horizon still open	45,453	Form 4 · filed 2 days after the trade
2026-06-01	Lin Shao-Lee	director	Purchase	45,453	—	ownership Δ n/a	+19.2%	not yet — horizon still open	45,453	Form 4 · filed 2 days after the trade
2025-12-30	Sarraf Pasha	director	Purchase	86,947 @ $0.32	$28K	+106.8% of holding	+10.0%	+202.6%	168,324	Form 4 · filed 3 days after the trade
2025-12-30	Sarraf Pasha	director	Purchase	78,116 @ $0.31	$24K	+46.4% of holding	+10.0%	+202.6%	246,440	Form 4 · filed 3 days after the trade
2025-12-30	Sarraf Pasha	director	Purchase	77,417 @ $0.30	$23K	+31.4% of holding	+10.0%	+202.6%	323,857	Form 4 · filed 3 days after the trade
2025-12-30	Sarraf Pasha	director	Purchase	77,148 @ $0.30	$23K	+1824.3% of holding	+10.0%	+202.6%	81,377	Form 4 · filed 3 days after the trade
2025-12-30	Sarraf Pasha	director	Purchase	4,229 @ $0.31	$1K	ownership Δ n/a	+10.0%	+202.6%	4,229	Form 4 · filed 3 days after the trade
2024-12-16	PASSERI DANIEL R	director	Purchase	30,000 @ $1.03	$31K	+22.3% of holding	+29.6%	−30.2%	164,578	Form 4 · filed 2 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

49 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

Date	Person	Role	Action	Shares	Owned after	Filing
2026-08-13	Ray Sumita	director	Option exercise	18,196	127,374	Form 4
2026-08-13	Meluzio Michael Vincent	officer	Option exercise	13,647	27,295	Form 4
2026-08-13	Ray Sumita	director	Option exercise	18,196	36,393	Form 4
2026-08-13	Meluzio Michael Vincent	officer	Option exercise	13,647	54,589	Form 4
2026-08-12	Lin Shao-Lee	director	Option exercise	109,179	218,358	Form 4
2026-08-12	Lin Shao-Lee	director	Option exercise	109,179	764,253	Form 4
2026-07-30	Ahlers James M	officer	Award / grant	51,000	51,000	Form 4
2026-07-30	Ahlers James M	officer	Award / grant	25,500	25,500	Form 4
2026-07-13	Borie Dominique Christian	officer	Award / grant	31,500	31,500	Form 4
2026-07-13	Borie Dominique Christian	officer	Award / grant	63,000	63,000	Form 4
2026-07-09	Meehan Viola Mong	director	Award / grant	21,800	21,800	Form 4
2026-07-09	Meluzio Michael Vincent	officer	Award / grant	40,942	40,942	Form 4
2026-07-09	Ray Sumita	director	Award / grant	54,589	109,178	Form 4
2026-07-09	Camardo Daniel A.	director	Award / grant	21,800	21,800	Form 4
2026-07-09	Ray Sumita	director	Award / grant	54,589	54,589	Form 4
2026-07-09	Lin Shao-Lee	director	Award / grant	327,537	655,074	Form 4
2026-07-09	Lin Shao-Lee	director	Award / grant	327,537	327,537	Form 4
2026-07-09	Garzone Pamela	director	Award / grant	21,800	21,800	Form 4
2026-07-09	Sarraf Pasha	director	Award / grant	21,800	32,595	Form 4
2026-05-30	Meehan Viola Mong	director	Award / grant	1,626	1,626	Form 4
2026-05-30	Camardo Daniel A.	director	Award / grant	1,626	1,626	Form 4
2026-05-03	Lin Shao-Lee	director	Award / grant	327,537	327,537	Form 4
2026-05-03	Lin Shao-Lee	director	Award / grant	655,074	655,074	Form 4
2026-04-09	Sandercock Colin	officer	Award / grant	200,000	200,000	Form 4
2026-04-09	Warren Lucinda	officer	Award / grant	250,000	250,000	Form 4
2026-04-09	Baker Daniel G.	director	Award / grant	100,000	100,000	Form 4
2026-01-02	Verheyen Patrick	director	Award / grant	24,400	24,400	Form 4
2026-01-02	Kiener Peter A	director	Award / grant	24,400	24,400	Form 4
2026-01-02	Sarraf Pasha	director	Award / grant	24,400	24,400	Form 4
2026-01-02	Broadfoot Jill Marie	director	Award / grant	24,400	24,400	Form 4
2026-01-02	Morich Frank	director	Award / grant	24,400	24,400	Form 4
2026-01-02	Garzone Pamela	director	Award / grant	24,400	24,400	Form 4
2025-12-03	Sandercock Colin	officer	Award / grant	70,000	70,000	Form 4
2025-09-29	Warren Lucinda	officer	Award / grant	125,000	125,000	Form 4
2025-09-29	Baker Daniel G.	director	Award / grant	50,000	50,000	Form 4
2025-09-29	Azam Usman	director	Award / grant	1,875,000	1,875,000	Form 4
2025-09-26	Sandercock Colin	officer	Award / grant	30,000	30,000	Form 4
2025-06-04	Broadfoot Jill Marie	director	Award / grant	48,800	48,800	Form 4
2025-03-21	Levisetti Matteo	officer	Award / grant	250,000	250,000	Form 4
2025-03-21	PASSERI DANIEL R	director	Award / grant	450,000	450,000	Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Resolves in i

28d remaining

2026-09-173% elapsed2026-10-15

Logged immutably 2026-09-17; scored automatically on 2026-10-15 — no edits, ever.

Earnings & context analysis

These panels are being prepared. They are generated by multiple language models, checked, and stored before display — never written live for a page view. Until a model panel has been generated and reviewed for a company, nothing is shown here, honestly, rather than a placeholder.

Calibration i

Every forecast is logged when made and scored when the month is up. The record is shown from the day it starts — young and honest.

How scoring works →

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

Reported insider & political trades

Congressional disclosures

Seasonality · by month i